A week after launching a new comprehensive consulting and technology program to help hospitals manage orthopedic surgery episodes-of-care, Zimmer Biomet Holdings Inc. is adding in vitro diagnostics to the program with an acquisition of CD Diagnostics.
On Aug. 15, Zimmer Biomet announced plans to acquire the Claymont, Del.-based company, which specializes in diagnostics based on biomarkers...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?